The UT Health Science Center at Houston > Neuroscience Research Center > Resources > Single Photon Emission Computed Tomography (SPECT)
See Also: NRC Membership Listing > Single Photon Emission Computed Tomography (SPECT)
... A medical imaging technique that uses small amounts of radioactive material (radioisotopes) attached to radiopharmaceuticals to map brain function
Single Photon Emission Computed Tomography (SPECT) is a medical imaging technique used for mapping brain metabolism and function. SPECT is similar to positron emission tomography in that once the radio-pharmaceutical is trapped in the brain, radiation is given off as a result of gamma emission. Various radioactive pharmaceuticals are injected into the blood and attach to targets in the brain’s gray matter for several hours. This allows researchers to image up to several hours after injection, yet study activity at the time of injection. Special detectors produce pictures of the radioisotopes in the brain, permitting scientists to distinguish between normal and abnormal tissue. This scanning procedure is somewhat the reverse of a traditional x-ray; instead of the x-rays coming from outside the body, the radiation source is inside the body.
At The University of Texas Health Science Center at Houston, SPECT technology is used to study:
Across the country, brain SPECT has been used to study various receptors, or groups of cells that receive stimuli. Receptors for the brain chemicals dopamine and serotonin have been studied, as well as receptors for opiates. Brain SPECT also can be used in identifying the location of brain tumors and in conjunction with agents that help detect brain tumors. The Division of Nuclear Medicine at UT-Houston, for example, uses Thalium-201 to evaluate recurrences of brain tumors after therapy – a process that can be very difficult with technologies that provide only images of structures in the body, such as MRI.